Oral Surgery Virtual Reality Glasses Study

Last updated: November 27, 2025
Sponsor: Boston University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Panic Disorders

Anxiety Disorders

Treatment

Virtual reality (VR) glasses with relaxation module

Clinical Study ID

NCT06723158
H-45038
  • Ages 16-65
  • All Genders

Study Summary

The goal of this randomized trial is to investigate if using virtual reality (VR) glasses for patients who require non-emergent oral surgery procedures under intravenous (IV) sedation improves their overall experience compared to using standard of care safety glasses.

This study has two primary objectives.

  1. To evaluate if VR glasses can improve patient tolerance during IV access, sedation induction, and the surgical procedure.

  2. To investigate whether the use of VR glasses reduces the amount of sedation required for induction and throughout the oral surgery procedure.

80 subjects will be randomly assigned 1:1 to either wear VR glasses playing a relaxing video and audio or VR glasses that will only serve as eye protection (control group).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients requiring IV sedation for oral surgery procedure

  • Patients able to understand the use of virtual reality glasses and provide informedconsent/assent

  • Patients classified as American Society of Anesthesiologists (ASA) I or II

  • No reported substance use within the previous 24 hours

  • No reported excessive alcohol consumption

  • Willingness to wear eye protection

  • Willingness to use certified interpreters if required

  • A legal guardian must accompany minors

Exclusion

Exclusion Criteria:

  • Patient with hearing aids or severe hearing impairment

  • Patient with blindness or significant visual impairment that is not corrected bycontact lenses

  • Patients with cognitive impairments determined and assessed by the researchers

  • Pregnant women or women who could be pregnant based on self reporting

  • Patients unable to tolerate virtual reality glasses due to motion sickness or otherissues

  • Patients with history of seizures or epilepsy per self report

  • Patients who cannot tolerate VR glasses due to discomfort or a medical emergencythat arises during the procedure

Study Design

Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Virtual reality (VR) glasses with relaxation module
Phase:
Study Start date:
November 18, 2025
Estimated Completion Date:
March 31, 2026

Connect with a study center

  • Goldman School of Dental Medicine, Oral and Maxillofacial Surgery Clinic

    Boston, Massachusetts 02118
    United States

    Site Not Available

  • Goldman School of Dental Medicine, Oral and Maxillofacial Surgery Clinic

    Boston 4930956, Massachusetts 6254926 02118
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.